GoAI
Get started
The People's Insurance Company (Group) of China Limited logo

The People's Insurance Company (Group) of China Limited

1339.HK

HKSEFinancial ServicesInsurance - Property & Casualty

Open in GoAI

Latest quote

HK$5.29

+HK$0.015 · +0.28%

Aug 24, 4:08 PM HKT

1339.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

The People's Insurance Company (Group) of China Limited functions as an investment holding enterprise, primarily conducting insurance activities throughout the People's Republic of China. Its operations are structured across several key divisions: Non-Life Insurance, Life Insurance, Health Insurance, Asset Management, and various other services. The company's property and casualty offerings cover a wide range of needs, including motor vehicle, commercial property, liability, credit, accidental injury and health, cargo, and agricultural insurance products. For life coverage, it provides general life and health, participating life, universal life, and accident insurance policies. Its health insurance portfolio includes medical, illness, nursing care, accidental injury, disability loss, and participating endowment plans. Furthermore, the company is involved in asset management, acts as an insurance agent, undertakes reinsurance, and delivers comprehensive financial products and services. Founded in 1949, this company is headquartered in Beijing, China.

Industry
Insurance - Property & Casualty
Sector
Financial Services
Headquarters
CN
CEO
Xiangqun Ding
Listed since
Dec 7, 2012
Employees
179,898

Market position

Day range

Current HK$5.29

52-week range

Current HK$5.29

Open
HK$5.26
Previous close
HK$5.275
Volume
15.46M
0.34× average
Average volume
45.24M
Average daily volume
Market cap
280.99B HKD
Beta
0.61
Market reference 1
50-day average
HK$5.1616
+2.49% above average
200-day average
HK$5.9944
-11.75% below average

Earnings

EPS beat rate
60%
6 beats, 4 misses, 0 met estimates
Average EPS surprise
+123.83%
10 comparable reports
Latest EPS result
0.23
Estimate 0.35 · Miss by 34.38%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.670.410.16-0.09Q4 '24BeatQ4 '24No estimateQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26MissQ2 '26MissQ3 '26Estimate
Q4 2024, reported Oct 29, 2024: actual 0.343, estimate -0.037, surprise +1039.21%, Beat. Q4 2024, reported Dec 31, 2024: actual 0.158, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Apr 29, 2025: actual 0.447, estimate 0.426, surprise +5.00%, Beat. Q3 2025, reported Aug 27, 2025: actual 0.339, estimate 0.614, surprise -44.76%, Miss. Q4 2025, reported Oct 30, 2025: actual 0.503, estimate 0.407, surprise +23.56%, Beat. Q1 2026, reported Mar 26, 2026: actual 0.49, estimate 0.579, surprise -15.42%, Miss. Q2 2026, reported Apr 29, 2026: actual 0.228, estimate 0.347, surprise -34.38%, Miss. Q3 2026, reported Aug 28, 2026: actual —, estimate 0.36, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates588.34B424.12B259.9B95.68BQ4 '24MissQ4 '24No estimateQ2 '25MissQ3 '25BeatQ4 '25EstimateQ1 '26MissQ2 '26MissQ3 '26Estimate
Q4 2024, reported Oct 29, 2024: actual 178.28B HKD, estimate 273.01B HKD, surprise -34.70%, Miss. Q4 2024, reported Dec 31, 2024: actual 121.6B HKD, estimate —, surprise —, Comparison unavailable. Q2 2025, reported Apr 29, 2025: actual 117.9B HKD, estimate 287.37B HKD, surprise -58.97%, Miss. Q3 2025, reported Aug 27, 2025: actual 426.61B HKD, estimate 329.88B HKD, surprise +29.32%, Beat. Q4 2025, reported Oct 30, 2025: actual —, estimate 322B HKD, surprise —, Comparison unavailable. Q1 2026, reported Mar 26, 2026: actual 112.57B HKD, estimate 316.06B HKD, surprise -64.38%, Miss. Q2 2026, reported Apr 29, 2026: actual 149.27B HKD, estimate 340.49B HKD, surprise -56.16%, Miss. Q3 2026, reported Aug 28, 2026: actual —, estimate 553.1B HKD, surprise —, Comparison unavailable.

1339.HK peers

Industrial and Commercial Bank of China Limited logo

1398.HK

Industrial and Commercial Bank of China Limited

HK$7.46

-0.20%

HSBC Holdings plc logo

0005.HK

HSBC Holdings plc

HK$161.5

-0.86%

Bank of China Limited logo

3988.HK

Bank of China Limited

HK$5.485

-0.36%

China Construction Bank Corporation logo

0939.HK

China Construction Bank Corporation

HK$9.175

-0.76%

Agricultural Bank of China Limited logo

1288.HK

Agricultural Bank of China Limited

HK$6.235

-0.72%

China Life Insurance Company Limited logo

2628.HK

China Life Insurance Company Limited

HK$28.66

+2.14%

ETFs holding 1339.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
90.33M
Weight
0.01%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.055-0.75%
Vanguard FTSE Emerging Markets ETF logoVanguard FTSE Emerging Markets ETFVWO
Market value
84.37M
Weight
0.05%
AUM
162.3B USD
Expense ratio
0.06%
Price / 1D
$59.8597-0.98%
iShares Core MSCI Emerging Markets ETF logoiShares Core MSCI Emerging Markets ETFIEMG
Market value
69.81M
Weight
0.04%
AUM
160B USD
Expense ratio
0.09%
Price / 1D
$80.285-1.58%
Avantis Emerging Markets Equity ETF logoAvantis Emerging Markets Equity ETFAVEM
Market value
21.16M
Weight
0.08%
AUM
27.89B USD
Expense ratio
0.33%
Price / 1D
$92.79-1.53%
iShares China Large-Cap ETF logoiShares China Large-Cap ETFFXI
Market value
20.35M
Weight
0.47%
AUM
4.27B USD
Expense ratio
0.73%
Price / 1D
$35.51-0.98%
iShares MSCI Emerging Markets ETF logoiShares MSCI Emerging Markets ETFEEM
Market value
14.78M
Weight
0.05%
AUM
31.22B USD
Expense ratio
0.72%
Price / 1D
$65.91-1.80%
iShares MSCI China ETF logoiShares MSCI China ETFMCHI
Market value
14.29M
Weight
0.23%
AUM
6.29B USD
Expense ratio
0.59%
Price / 1D
$54.865-1.43%
Vanguard FTSE All-World ex-US ETF logoVanguard FTSE All-World ex-US ETFVEU
Market value
14.2M
Weight
0.01%
AUM
95.9B USD
Expense ratio
0.04%
Price / 1D
$85.045-0.75%

Continue in GoAI

Research 1339.HK

research.disclaimer